CRISPR-Cas9-mediated gene therapy in neurological disorders

L Guan, Y Han, C Yang, S Lu, J Du, H Li, J Lin - Molecular Neurobiology, 2022 - Springer
Neurological disorders are primarily diseases with sophisticated etiology that are always
refractory and recrudescent. The major obstruction to effective therapies for neurological …

CRISPR-editing therapy for Duchenne Muscular Dystrophy

F Chemello, EN Olson, R Bassel-Duby - Human gene therapy, 2023 - liebertpub.com
Duchenne muscular dystrophy (DMD) is a debilitating genetic disorder that results in
progressive muscle degeneration and premature death. DMD is caused by mutations in the …

Systemic deletion of DMD exon 51 rescues clinically severe Duchenne muscular dystrophy in a pig model lacking DMD exon 52

M Stirm, B Shashikadze, A Blutke… - Proceedings of the …, 2023 - National Acad Sciences
Duchenne muscular dystrophy (DMD) is a fatal X-linked disease caused by mutations in the
DMD gene, leading to complete absence of dystrophin and progressive degeneration of …

[HTML][HTML] CRISPR-induced deletion with SaCas9 restores dystrophin expression in dystrophic models in vitro and in vivo

BL Duchêne, K Cherif, JP Iyombe-Engembe, A Guyon… - Molecular Therapy, 2018 - cell.com
Duchenne muscular dystrophy (DMD), a severe hereditary disease affecting 1 in 3,500 boys,
mainly results from the deletion of exon (s), leading to a reading frameshift of the DMD gene …

In Vivo Ryr2 Editing Corrects Catecholaminergic Polymorphic Ventricular Tachycardia

X Pan, L Philippen, SK Lahiri, C Lee, SH Park… - Circulation …, 2018 - Am Heart Assoc
Rationale: Autosomal-dominant mutations in ryanodine receptor type 2 (RYR2) are
responsible for≈ 60% of all catecholaminergic polymorphic ventricular tachycardia …

CRISPR/Cas-Dependent and Nuclease-Free In Vivo Therapeutic Gene Editing

I Dasgupta, TR Flotte, AM Keeler - Human gene therapy, 2021 - liebertpub.com
Precise gene manipulation by gene editing approaches facilitates the potential to cure
several debilitating genetic disorders. Gene modification stimulated by engineered …

CRISPR-Cas9 genome engineering: treating inherited retinal degeneration

ER Burnight, JC Giacalone, JA Cooke… - Progress in retinal and …, 2018 - Elsevier
Gene correction is a valuable strategy for treating inherited retinal degenerative diseases, a
major cause of irreversible blindness worldwide. Single gene defects cause the majority of …

CRISPR/Cas9 gene-editing strategies in cardiovascular cells

E Vermersch, C Jouve, JS Hulot - Cardiovascular research, 2020 - academic.oup.com
Cardiovascular diseases are among the main causes of morbidity and mortality in Western
countries and considered as a leading public health issue. Therefore, there is a strong need …

[HTML][HTML] CRISPR-based therapeutic gene editing for Duchenne muscular dystrophy: advances, challenges and perspectives

G Chen, T Wei, H Yang, G Li, H Li - Cells, 2022 - mdpi.com
Duchenne muscular dystrophy (DMD) is a severe neuromuscular disease arising from loss-
of-function mutations in the dystrophin gene and characterized by progressive muscle …

Therapeutic applications of CRISPR/Cas9 system in gene therapy

H Mollanoori, S Teimourian - Biotechnology letters, 2018 - Springer
Gene therapy is based on the principle of the genetic manipulation of DNA or RNA for
treating and preventing human diseases. The clustered regularly interspaced short …